Walleye Trading
AVDL

Walleye Trading’s Avadel Pharmaceuticals AVDL Stock Holding History

Walleye Trading’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-73,900
Closed -$1.59M – 4116
2025
Q4 		$1.59M Buy
+73,900
New +$1.43M ﹤0.01% 2060
2025
Q2 		– Sell
-7,900
Closed -$61.9K – 4212
2025
Q1 		$61.9K Buy
+7,900
New +$66.2K ﹤0.01% 3554
2022
Q3 		– Sell
-10,900
Closed -$27K – 5020
2022
Q2 		$27K Sell
10,900
-4,300
-28% -$17.7K ﹤0.01% 4470
2022
Q1 		$104K Buy
+15,200
New +$104K ﹤0.01% 4216
2021
Q2 		– Sell
-8,200
Closed -$74K – 5131
2021
Q1 		$74K Buy
8,200
+3,000
+58% +$24.3K ﹤0.01% 4207
2020
Q4 		$35K Sell
5,200
-40,100
-89% -$251K ﹤0.01% 4293
2020
Q3 		$228K Buy
45,300
+6,200
+16% +$45.1K ﹤0.01% 2909
2020
Q2 		$316K Sell
39,100
-144,300
-79% -$1.27M ﹤0.01% 2666
2020
Q1 		$1.46M Buy
183,400
+131,700
+255% +$1.01M 0.01% 1045
2019
Q4 		$390K Buy
+51,700
New +$273K ﹤0.01% 2616

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's AVDL Position: Q1 2020 in Review

Walleye Trading sold out of Avadel Pharmaceuticals (AVDL) in Q1 2020, closing a stake of 4,154 shares — an estimated $31.9K sold.

Walleye Trading first reported a position in AVDL in Q3 2015 and held it in 11 quarters. The position peaked at $165K in Q3 2016. 56 funds tracked by Wall St. Rank hold AVDL as of Q1 2020.

  • Walleye Trading reported no remaining Avadel Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Walleye Trading sold 4,154 Avadel Pharmaceuticals shares in Q1 2020, an estimated $31.9K.
  • Walleye Trading first reported a position in Avadel Pharmaceuticals in Q3 2015 and held it in 11 quarters.
  • Walleye Trading's Avadel Pharmaceuticals position peaked at $165K in Q3 2016.
  • 56 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2020.

Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.